.Merck & Co.'s TIGIT course has actually experienced yet another setback. Months after shuttering...
.After a year described by pipeline hairstyles, the variation of its own chief executive officer and...
.Cullinan Therapeutics was actually impressed sufficient with Harbour BioMed's bispecific immune act...
.Within this full week's episode of "The Best Pipe," we are actually diving right into Intense Biote...
.The confetti is actually still flying coming from Eli Lilly's party celebrating the approval of Alz...
.Invite to today's Chutes & Ladders, our roundup of considerable management hirings, firings and ...
.Following a bad showing for Lykos Therapeutics' MDMA prospect for trauma at a recent FDA consultato...
.AN2 Therapies is actually reconsidering its service in feedback to poor midphase data, vowing to la...
.Merck & Co. is actually paying out $700 thousand in advance to test Amgen in a blood cancer mark...
.Along With Gilead Sciences almost an FDA choice for its own liver health condition drug seladelpar,...